SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,523,771 | -15.3% | 78,566 | -19.9% | 0.05% | -10.7% |
| Q2 2023 | $11,239,336 | -31.9% | 98,143 | -18.0% | 0.06% | -37.1% |
| Q1 2023 | $16,493,565 | +9.4% | 119,666 | +2.9% | 0.09% | +2.3% |
| Q4 2022 | $15,069,636 | -13.6% | 116,296 | -26.3% | 0.09% | -23.7% |
| Q3 2022 | $17,436,000 | +1204.1% | 157,731 | +784.1% | 0.11% | +1325.0% |
| Q2 2022 | $1,337,000 | +246.4% | 17,841 | +244.2% | 0.01% | +300.0% |
| Q1 2021 | $386,000 | -69.6% | 5,184 | -30.5% | 0.00% | -75.0% |
| Q4 2020 | $1,271,000 | +6.5% | 7,456 | -12.3% | 0.01% | 0.0% |
| Q3 2020 | $1,193,000 | +377.2% | 8,497 | +448.2% | 0.01% | +700.0% |
| Q3 2018 | $250,000 | – | 1,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |